Anna Pare, MD
Dermatology · Atlanta, GANPI 1437135274
Payments from drug & device makers
Across 596 payments — averaging $97.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$26K
- AbbVie$15K
- Aclaris Therapeutics, Inc.$6K
- Merz North America, Inc.$3K
- Sanofi$2K
- Revance Therapeutics, Inc.$1K
- plus $5K from 26 others
What the payments were for
- Consulting fees$12,40021%
- Speaking & faculty fees$22,90240%
- Travel & lodging$8,03614%
- Food & beverage$14,39225%
- Education$860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 84 | $26,381 |
| AbbVie(2 entities) | 168 | $15,232 |
| Aclaris Therapeutics, Inc. | 21 | $5,620 |
| Merz North America, Inc. | 18 | $2,688 |
| Sanofi | 47 | $1,966 |
| Revance Therapeutics, Inc. | 32 | $1,292 |
| Incyte Corporation | 35 | $780 |
| Novartis | 38 | $708 |
| Regeneron Healthcare Solutions, Inc. | 20 | $587 |
| E.r. Squibb & Sons, L.L.C. | 20 | $432 |
| Sun Pharmaceutical Industries Inc. | 19 | $350 |
| Lilly USA, LLC | 13 | $248 |
| UCB, Inc. | 12 | $244 |
| Pfizer | 13 | $236 |
| LEO Pharma Inc. | 9 | $203 |
| Johnson & Johnson | 9 | $170 |
| Mayne Pharma Commercial LLC | 9 | $117 |
| Dermavant Sciences, Inc. | 6 | $111 |
| Organogenesis Inc. | 2 | $64 |
| Amgen | 3 | $64 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $54 |
| Biofrontera Inc. | 2 | $43 |
| Botanix SB Inc | 2 | $40 |
| Almirall LLC | 2 | $33 |
| Organon | 2 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| EPI Health, LLC | 1 | $19 |
| LNHC, Inc | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Kerecis Limited | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,817 in reported general payments places this provider in the 85th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 85 | $1,189 |
| ValacyclovirValacyclovir Hcl | 34 | $662 |
| Clobetasol Propionate | 24 | $567 |
| Ketoconazole | 29 | $490 |
| Mupirocin | 41 | $229 |
| Triamcinolone Acetonide | 20 | $129 |
| Cephalexin | 19 | $50 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Jamie WeismanAtlanta$4.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$722K
- Ron FeldmanAtlanta$483K
- Jack ArbiserAtlanta$453K
- Mack RachalAtlanta$316K
- Tunisia CorneliusAtlanta$210K
- Emily AltmanAtlanta$178K
- Hailey RouhanaAtlanta$157K
- Lauren OrensteinAtlanta$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.